Navigation Links
Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences
Date:6/16/2009

PHILADELPHIA, June 16 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts today named 10 promising young scientists as Pew Latin American Fellows in the Biomedical Sciences. The rigorously competitive program provides $60,000 in salary support for postdoctoral level scientists to work with leading researchers in the United States. Upon returning to Latin America, Fellows receive an additional $35,000 to purchase essential equipment to continue their research in their home countries.

"Pew's Latin American Fellows Program is designed to further the development of outstanding scientists by providing them with excellent training in high-quality scientific laboratories in the U.S.," said Rebecca W. Rimel, President and CEO of The Pew Charitable Trusts. "We are proud to invest in Latin America's scientific future. These Fellows will help lead the global advance of research to protect and promote the health of the public."

The Latin American Fellows Program is one of The Pew Charitable Trusts' two long-standing commitments in this field, which also includes the Pew Scholars in the Biomedical Sciences, a program for America's leading early-career scientists. The Fellows program was launched in 1991 to help develop a community of highly-trained researchers who could stimulate and contribute to the growth of important biomedical research, and to foster collaboration between scientists in Latin America and the U.S.

Since 1991, Pew has invested over $14 million to fund over 175 fellows, close to 80 percent of whom have returned to their home countries. Applicants from all Central and South American countries are invited to apply to the program, and selection is made by a distinguished national advisory committee, chaired by Dr. Torsten N. Wiesel, president emeritus of Rockefeller University and a 1981 Nobel laureate in physiology or medicine.

The 2009 Pew Latin American
'/>"/>

SOURCE The Pew Charitable Trusts
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
2. Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer
3. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer
4. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
5. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
6. Spiral Biotech to Introduce New Autoplate Spiral Plating System at ASM General Meeting in May
7. Palatin Technologies Listing Compliance Plan Accepted by NYSE Alternext US
8. Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
9. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
10. Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009
11. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 Amgen (NASDAQ: AMGN ) ... $0.61 per share dividend for the third quarter of ... 2014, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:7/25/2014)... 2014 According to a new market ... - Global Industry Analysis, Size, Share, Growth, Trends and ... is estimated at USD 161,056.5 million in 2014 and ... from 2014 to 2020, to reach an estimated value ... drugs market is witnessing a significant growth due to ...
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
Breaking Biology Technology:Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4
... of Wisconsin-Milwaukee (UWM) have discovered an entirely new ... kid" of the carbon family, graphene. The discovery, ... pushes carbon materials closer to ushering in next-generation ... that resembles a flat sheet of chicken wire ...
... Calif., April 16, 2012 WaferGen Bio-systems, Inc. ... a strategic realignment and new direction for the ... customers to perform accurate high-throughput qPCR projects for ... sequencing in a simpler and more cost-effective way.  ...
... MOORESVILLE, N.C., April 13, 2012 A recent solicitation ... Iosat Potassium Iodide has created a deluge of orders ... for troop support, the 130mg tablets provide protection against ... International concerns about the development of nuclear weaponry in ...
Cached Biology Technology:UWM discovery advances graphene-based electronics 2UWM discovery advances graphene-based electronics 3WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment 2WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment 3Potassium Iodide Sales Surge on Heels of Large Government Order 2
(Date:7/28/2014)... DUBLIN , July 28, 2014 ... the "Biometrics Market in Latin America 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biometrics measure and analyze biological ... facial patterns, irises, eye retinas, voice patterns, and hand ... one or more stored templates. The main purpose of ...
(Date:7/28/2014)... Engineering at Harvard University today announced that its ... newly formed private company to accelerate development of ... The announcement follows a worldwide license agreement ... the start-up Emulate Inc., relating to the use ... , "This is a big win towards achieving ...
(Date:7/27/2014)... has revealed that nicotine and cotinine, a metabolite of ... certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or ... and ultimately ends up in the tobacco smoke. Once ... where it is activated by a variety of enzymes ... revealed that nicotine can partially interfere with the activation ...
Breaking Biology News(10 mins):Biometrics Market in Latin America 2014-2018 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... climate change, researchers at BBSRC-supported Rothamsted Research have shown. ... aphid (Myzus persicae) has been found to be flying ... for January and February combined. This year, the first ... weeks ahead of the 42-year average. This work is ...
... the hundreds of species of woody vines that University of ... of Panama, the largest has a stalk nearly 20 inches ... Schnitzer. "And because it winds itself up to the forest ... as a community of trees." Such vines, called lianas, ...
... health care, computational biology, homeland security and other areas, ... proven cumbersome and difficult. An emerging research field known ... such mountains of information to find and put together ... of Technology has received a five-year grant to lead ...
Cached Biology News:Aphids are sentinels of climate change 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 3Grant supports emerging field of massive data analysis and visual analytics 2Grant supports emerging field of massive data analysis and visual analytics 3Grant supports emerging field of massive data analysis and visual analytics 4
... Cell Invasion Assay is designed to determine ... as a significant barrier to invasion or ... in a convenient, high-throughput, 96-well format. The ... all types of adherent cells such as ...
... design in ice/water bath This CLS ... created to easily match Cornings product ... please order under the old Sigma-Aldrich ... for assistance. ID clarifier: rack and ...
Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: